Details for 2016810283

Up to date per 01.04.2026

Actions

Title / Product Name

TYPE II ANTI-CD20 ANTIKÖRPER ZUR VERRINGERUNG DER BILDUNG VON ANTIKÖRPERN GEGEN MEDIKAMENTE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016810283

EP Publication Number

3387015

E-Number

1441746

Language

PCT Number

EP16079800

Publication Date

17.10.2018 A

27.10.2021 B1

Registration Date

27.10.2021

AT Publication Date

15.11.2021

Application Date

06.12.2016

Registration Number

Priorities

09.12.2015

15198715

02.06.2016

16172739

10.10.2016

16193151

IPC

C07K 16/28 20060101AFI20180515BHEP

Maximum Duration of Protection

06.12.2036

Owner

F. Hoffmann-La Roche AGGrenzacherstrasse 124 4070 BaselCH

Representative

Authorized Recipients

Dr. Georg Kalhammerc/o Lederer & Keller Patentanwälte Partnerschaft mbB, Unsöldstraße 280538 MünchenDE

Inventor

BACAC, Marinac/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

EVERS, Stefanc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

KLEIN, Christianc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

PISA, Pavelc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

ROSSMANN, Evac/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 BaselCH

SARO, Josec/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

UMAÑA, Pabloc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

Information about Fees